News

Phase V of COVID-19 survey finds 97% seropositivity among the elderly in six districts of Tamil Nadu
Phase V of COVID-19 serosurvey in Tamil Nadu shows 97% seropositivity among elderly, indicating high immunity levels.
SARS-CoV-2 virus could not cause severe illness, and deaths are almost nil in Tamil Nadu, says the latest Sero-Survey
Tamil Nadu's latest Sero survey reveals 97% immunity against Covid, attributed to vaccinations and natural infections.
Hansa Biopharma to attend BIO International Convention
Evan Ballantyne, Chief Financial [email protected] Stephanie Kenney, VP Global Corporate [email protected]   Notes to editors About Hansa Biopharma Hansa Biopharma AB is a ...
MarketersMEDIA Newsroom11h
Weston, FL Food Sensitivity Testing & Diet Protocols For Digestive Issues Update
Megan Pennington Integrative Health has announced updates to its food sensitivity and functional lab testing services for ...
TMCnet16h
argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease
ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod; RHO data show efgartigimod achieved susta ...